Target Healthcare REIT (LSE:THRL) Moat Score: 0/10 (As of Jul. 02, 2026)


LSE:THRL Target Healthcare REIT PLC LSE:THRL
32 GF Score
Price £1.09
GF Value £0.88
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Target Healthcare REIT Moat Score?

Target Healthcare REIT has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Target Healthcare REIT has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Target Healthcare REIT might have No Moat - No discernible moat.

Target Healthcare REIT  (LSE:THRL) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Target Healthcare REIT Moat Score Related Terms

LSE:THRL
32GF Score
Target Healthcare REIT PLC LSE:THRL
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Target Healthcare REIT (LSE:THRL) Overvalued in 2026?

Based on GuruFocus' analysis, Target Healthcare REIT stock appears to be overvalued. The current stock price of £1.09 is trading 23.6% above its estimated GF Value™ of £0.88. GuruFocus considers Target Healthcare REIT to be Modestly Overvalued.

Key valuation signals for LSE:THRL:

  • Moat Score: 0
  • GF Value™: £0.88 vs. price of £1.09 (23.6% above fair value)
  • GF Score™: 32/100 with 7 warning signs

No single metric tells the full story. See the LSE:THRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Target Healthcare REIT Business Description

Industry Real EstateREITs
Address 69 Old Broad Street, Level 4, Dashwood House, London, GBR, EC2M 1QS
Target Healthcare REIT PLC is an investment company that acts as a long-term investor in care homes in the United Kingdom. The investment objective of the company is to provide shareholders with an attractive level of income together with the potential for capital and income growth from investing in a diversified portfolio of freehold and long-leasehold care homes, which are let to care home operators, and other healthcare assets in the United Kingdom.
32GF Score

Get the complete analysis for LSE:THRL

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£1.09
Price
£0.88
GF Value